Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Finasteride causes reproductive changes in male rats.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

The black orchid Brasiliorchis schunkeana produces chemicals that attract certain insects and have potential antimicrobial properties.

Nutrafol might help reduce hair loss due to inflammation, but more evidence is needed.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Antiandrogens and finasteride may help treat excess hair and hair loss in women.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Certain chemicals and peptides can promote hair growth or prevent baldness.

Male pattern baldness is mainly caused by genetics and hormones, treatable with minoxidil and finasteride.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Different causes of hair loss require specific treatments, and most men and women will experience some form of hair thinning as they age.

New compounds may help treat prostate issues without affecting androgen receptors.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

Breezula® may be more effective than Minoxidil in promoting hair growth by reducing a hair growth inhibitor.

DHEA inhibits growth in both mouse and human melanoma cells but works differently in each.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

DHT stops hair regrowth in mice, similar to human hair loss.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.